Shots:

• Merck Animal Health to acquire the US rights to Sentinel flavor tabs and chews in the companion animal category- under the agreement with Virbac. The transaction is expected to be closed by mid-2020
• With the acquisition- Merck expects to provide veterinarians continuous parasite protection for dogs in easy to administer- palatable formulations
• The products will target different parts of the flea lifecycle offering broad-spectrum- internal parasite protection in the Sentinel brand and the extended duration flea and tick protection of Bravecto

­ Ref: Merck Animal Health | Image: Merck